Sonnet BioTherapeutics Plans Shift to Hyperliquid Strategies, Potentially Becoming Major U.S. Holder of HYPE Token
1 min read
Sonnet BioTherapeutics is strategically pivoting from biotech to crypto by merging with Rorschach to form Hyperliquid Strategies, targeting significant holdings in the HYPE token. This $888 million entity aims to
Source: CoinOtag
